Telling People That Their Weight is Immunosuppressive is Not Fat-Shaming

Doctors have an ethical obligation to let their patients know this important consequence of obesity.

By Popular Rationalism Editorial Team

Introduction

In a time when health messaging has become a political minefield, it is critical that we draw a clear line between scientific truth and emotional connotation. The statement that obesity impairs immune function is not fat-shaming—it is a medically established, reproducible, and mechanistically supported reality. When well-documented biological facts are suppressed for fear of offending sensibilities, public health suffers.

We tell smokers they’re at greater risk for lung cancer. We tell sedentary people to move more and about the risks of cardiovascular disease and diabetes. And we must also tell those with obesity: your immune system doesn’t function the same way—and this matters.

What This Means for You

If you’re a patient, clinician, or policymaker, here’s the bottom line:

• Obesity doesn’t just affect cardiovascular or metabolic health—it alters how your immune system responds to infection and vaccines.

• This is not your fault. But it is your biology and it represent a modifiable health impact factor.

• Knowing this opens up actionable options, from managing expectations of vaccine efficacy to restricted social engagements to reduce one’s personal risk.

Obesity and the Immune System: What the Science Says

Obesity is not just excess fat—it is a chronic inflammatory state. Adipose tissue secretes cytokines like TNF-α, IL-6, and MCP-1, which impair both innate and adaptive immunity. This low-grade inflammation interferes with:

• Antigen presentation

• CD4+ and CD8+ T-cell activation

• Memory formation

• Antibody quality and durability

Vaccine Response: Human Data

• A 2012 study by Sheridan et al. found that while individuals with obesity had strong initial IgG responses after influenza vaccination, their antibody levels waned more rapidly and CD8+ T-cell function was impaired. 1

• In a 2017 study by Neidich et al., vaccinated adults with obesity were twice as likely to get laboratory-confirmed influenza or flu-like illness compared to those with healthy weight—even though antibody titers were similar. 2

• Fan et al. conducted a meta-analysis of 16 studies and found that obesity more than doubles the risk of non-response to hepatitis B vaccination. 3

• In COVID-19, Ou et al. and van der Klaauw et al. independently reported that individuals with obesity had lower antibody titers, accelerated waning, and higher rates of hospitalization despite full vaccination. 6 7

• Even in children, Eliakim et al. showed that overweight kids had lower tetanus antibody levels, suggesting this effect begins early in life. 9

Dose–Response Relationships

Data from Joshi et al. show a clear gradient: participants with BMI >35 had lower hepatitis B titers and reduced CD4+ T-cell responses compared to those with BMI <35. The mechanism involved dysfunctional pTFH (peripheral follicular helper T cells). 5

Mechanisms: Why Obesity Impairs Immune Responses

Myth vs Fact

Real-World Implications

If 42% of U.S. adults have obesity (CDC), vaccine campaign models may be overestimating effectiveness if they ignore this variable. Booster recommendations should consider BMI and rate of waning immunity, and needle-length guidelines must be standardized to prevent subcutaneous delivery in individuals with high deltoid adiposity.

In the 1985 JAMA study by Weber et al., hospital staff who received hepatitis B vaccines with 1-inch needles into the buttock (vs deltoid) had only 56% seroconversion, largely due to inadvertent subcutaneous placement—an effect magnified in higher-BMI individuals. 4

If You’re Thinking “This Sounds Like Blame,” Read This

This isn’t about blame. We’re not saying “you caused this” any more than we’d say that to someone with asthma or rheumatoid arthritis. We’re saying:

You deserve to know how your immune system works so that you can protect yourself and your family.

That is respect. That is autonomy.

Policy Recommendations

1. Update CDC/FDA guidelines to include obesity as a vaccine risk modifier

2. Revise needle-length standards for high-BMI patients

3. Include BMI and NAFLD in trial subgroup analyses

4. Fund longitudinal studies tracking antibody durability in obesity

5. Empower clinicians to offer titer checks and booster timing based on metabolic profiles

Conclusion

It is not fat-shaming to say that immune response is altered by obesity. It is biological truth backed by decades of data. Suppressing this knowledge in the name of sensitivity causes harm—especially during pandemics.

As with any health risk, the goal is not to assign blame, but to optimize outcomes. Whether that means earlier boosters, better injection protocols, or metabolic therapies to improve immune resilience, the path forward begins with honesty.

The US Department of Health and Human Services should hold a workshop on what to do about the link between immunity and obesity to determine if updated vaccination protocols are needed - and to determine what the effects of obesity are on fighting infections of all types.

Let’s respect people enough to tell them truths that can help them.

References

1. Sheridan PA, Paich HA, Handy J, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond). 2012;36(8):1072–1077. doi:10.1038/ijo.2011.208. PMID: 22024641

2. Neidich SD, Green WD, Rebeles J, et al. Increased risk of influenza among vaccinated adults who are obese. Int J Obes (Lond). 2017;41(9):1324–1330. doi:10.1038/ijo.2017.131. PMID: 28584297

3. Fan W, Chen XF, Shen C, Guo ZR, Dong C. Hepatitis B vaccine response in obesity: A meta-analysis. Vaccine. 2016;34(40):4835–4841. doi:10.1016/j.vaccine.2016.08.027. PMID: 27546877

4. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a Predictor of Poor Antibody Response to Hepatitis B Plasma Vaccine. JAMA. 1985;254(22):3187–3189. doi:10.1001/jama.1985.03360220053027. PMID: 2933532

5. Joshi SS, Davis RP, Ma MM, et al. Reduced immune responses to hepatitis B primary vaccination in obese individuals with NAFLD. NPJ Vaccines. 2021;6(1):9. doi:10.1038/s41541-020-00266-4. PMID: 33431890

6. Ou X, Jiang J, Lin B, et al. Antibody responses to COVID-19 vaccination in people with obesity: A systematic review and meta-analysis. Influenza Other Respir Viruses. 2023;17(1):e13078. doi:10.1111/irv.13078. PMID: 36535669

7. van der Klaauw AA, Horner EC, Pereyra-Gerber P, et al. Accelerated waning of the humoral response to COVID-19 vaccines in obesity. Nat Med. 2023;29(5):1146–1154. doi:10.1038/s41591-023-02343-2. PMID: 37169862

8. Park H-L, Shim S-H, Lee E-Y, et al. Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine. Hum Vaccin Immunother. 2014;10(5):1181–1186. doi:10.4161/hv.28332. PMID: 24614530

9. Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in overweight children. Autoimmunity. 2006;39(2):137–141. doi:10.1080/08916930600597326. PMID: 16698670